Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleCombination of ruxolitinib with ABT-737 exhibits synergistic effects in cells carrying concurrent JAK2<sup>V617F</sup> and ASXL1 mutations.AuthorsYuan, Jiajia; Song, Junzhe; Chen, Chao; Lv, Xue; Bai, Jie; Yang, Jing; Zhou, YuanPublicationInvestigational New Drugs, 2022, Vol 40, Issue 6, p1194ISSN0167-6997Publication typeArticleDOI10.1007/s10637-022-01297-5